Noriyuki Kaji

Dr. Noriyuki Kaji


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Pharmacological Research
Verified
Journal Article
Closed access
NKNoriyuki Kaji
Noriyuki Kaji
KHKazuhide Horiguchi
Kazuhide Horiguchi
SISatoshi Iino
Satoshi Iino
SNShinsuke Nakayama
Shinsuke Nakayama
TOTomohiko Ohwada
Tomohiko Ohwada
MHMasatoshi Hori
Masatoshi Hori

14 June 2016 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
MIM S Islam
M S Islam
KHK Horiguchi
K Horiguchi
SIS Iino
S Iino
NKNoriyuki Kaji
Noriyuki Kaji
SMS Mikawa
S Mikawa
HOH Ozaki
H Ozaki
Background and Purpose: IL‐33 is a novel cytokine that is believed to be involved in inflammation and carcinogenesis. However, its source, its production and its secretion process remain unclear. Recently, we have reported that IL‐33 is up‐regulated in dextran sulfate sodium (DSS) colitis in mice.Experimental Approach: Production of IL‐33 from intestinal tissue was studied in a murine cancer model induced by azoxymethane (AOM) and DSS in vivo and in cultures of IEC‐6 epithelial cells. Cytokine levels were measured by real time PCR, immunohistochemistry and elisa.Key Results: Mice with AOM/DSS‐induced colitis expressed all the characteristic symptoms of colon cancer pathology. Immunohistochemical analysis demonstrated epithelial cell‐derived IL‐33 in colon tissues from mice with AOM/DSS colitis. Real time PCR and quantitative PCR analysis revealed that AOM/DSS colitis tissues expressed up‐regulated IL‐1β, IL‐33, TGF‐β, and EGF mRNA. Gefitinib, an EGFR inhibitor, inhibited IL‐33 mRNA expression in AOM/DSS colitis mice. The pathophysiological role of IL‐33 in the rat intestinal epithelial cell line (IEC‐6 cells) was then investigated. We found that EGF, but not TGF‐β1 or PDGF, greatly enhanced mRNA expression of IL‐33 and its receptor ST2. In accordance with the gene expression and immunohistochemical analysis of IL‐33 levels, elisa‐based analysis of cytoplasmic and nuclear extracts showed increased IL‐33 protein levels in IEC‐6 cells after treatment with EGF.Conclusions and Implications: Our results suggest that EGF is a key growth factor that increased IL‐33 production and ST2 receptor expression during intestinal inflammation and carcinogenesis. The EGF/IL‐33/ST2 axis represents a novel therapeutic target in colon cancer.

1 May 2013 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
SMShingo Maeda
Shingo Maeda
SMSadatoshi Maeda
Sadatoshi Maeda
KOKoichi Ohno
Koichi Ohno
NKNoriyuki Kaji
Noriyuki Kaji
MHMasatoshi Hori
Masatoshi Hori
HTHajime Tsujimoto
Hajime Tsujimoto

10 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HKHitomi Kimura
Hitomi Kimura
YIYu-Ki Imura
Yu-Ki Imura
HTHirotaka Tomiyasu
Hirotaka Tomiyasu
TMTaiki Mihara
Taiki Mihara
NKNoriyuki Kaji
Noriyuki Kaji
MHMasatoshi Hori
Masatoshi Hori
Gastrointestinal prokinetic agents function as serotonin-4 receptor (5-HT4R) agonists to activate myenteric plexus neurons to release acetylcholine (ACh), which then induce anti-inflammatory action. Details of this pathway, however, remain unknown. The aim of this study is to clarify the anti-inflammatory mechanism underlying the 5-HT4R agonist, mosapride citrate (MOS)-induced anti-inflammatory action on postoperative ileus (POI). POI models were generated from wild-type C57BL6/J (WT), 5-HT4R knock-out (S4R KO), α7 nicotinic AChR KO (α7 R KO), and M2 muscarinic ACh receptor KO (M2R KO) mice. MOS attenuated leukocyte infiltration in WT. MOS-induced anti-inflammatory action was completely abolished in both S4R KO and S4R KO mice upon wild-type bone marrow transplantation. MOS-induced anti-inflammatory action against macrophage infiltration, but not neutrophil infiltration, was attenuated in α7 R KO mice. Selective α7nAChR agonists (PNU-282987 and AR-R17779) also inhibited only macrophage infiltration in POI. MOS-mediated inhibition of neutrophil infiltration was diminished by atropine, M2AChR antagonist, methoctramine, and in M2R KO mice. Stimulation with 5-HT4R inhibits leukocyte infiltration in POI, possibly through myenteric plexus activation. Released ACh inhibited macrophage and neutrophil infiltration likely by activation of α7nAChR on macrophages and M2AChR. Thus, macrophage and neutrophil recruitment into inflamed sites is regulated by different types of AChR in the small intestine.

15 March 2018 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
NKNoriyuki Kaji
Noriyuki Kaji
SNS. Nakayama
S. Nakayama
KHK. Horiguchi
K. Horiguchi
SIS. Iino
S. Iino
HOH. Ozaki
H. Ozaki
MHM. Hori
M. Hori

5 January 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
QYQunhui Yang
Qunhui Yang
WFWataru Fujii
Wataru Fujii
NKNoriyuki Kaji
Noriyuki Kaji
SKShigeru Kakuta
Shigeru Kakuta
KKKodai Kada
Kodai Kada
MHMasatoshi Hori
Masatoshi Hori
PKC‐potentiated phosphorylation‐dependent inhibitory protein of protein phosphatase 1 (CPI‐17), an endogenous myosin phosphatase inhibitory protein, is considered a key molecule for Ca 2+ sensitization of the contractile apparatus. Here, we have used clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR‐associated protein 9 to generate CPI‐17‐deficient [knockout (KO)] and threonine 38 (T38)‐phosphoresistant mice [threonine mutant into alanine (TA)], and then effects of CPI‐17 on vascular contractility in vitro and mean blood pressure (MBP) in vivo were investigated. In isolated thoracic aorta, phorbol 12,13‐dibutyrate induced a sustained contraction of wild‐type (WT) mice, whereas no contraction showed from TA or KO mice. A high concentration of KCl solution‐induced contraction was not different between transgenic and WT mice. In contrast, phenylephrine (PE)‐induced contractions in both mutant strains were significantly smaller than those of WT mice in association with a low level of myosin phosphorylation, suggesting that at least part of PE‐induced contraction is regulated by phosphorylation of CPI‐17 at T38. Finally, the physiologic role of CPI‐17 in the regulation of blood pressure was investigated using radio telemetry. MBP was decreased significantly in both transgenic mice, even with a compensatory increase in heart rate. In summary, we generated KO and constitutively phospho‐resistant mouse models of CPI‐17 for the first time. p‐CPI‐17 at T38, possibly by PKC, could be important to maintain vascular contractility and blood pressure in vivo.— Yang, Q., Fujii, W., Kaji, N., Kakuta, S., Kada, K., Kuwahara, M., Tsubone, H., Ozaki, H., Hori, M. The essential role of phospho‐T38 CPI‐17 in the maintenance of physiological blood pressure using genetically modified mice. FASEB J. 32, 2095–2109 (2018). www.fasebj.org